These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 14720070)

  • 1. Influenza vaccination: is it appropriate in chronic fatigue syndrome?
    Sleigh KM; Marra FH; Stiver HG
    Am J Respir Med; 2002; 1(1):3-9. PubMed ID: 14720070
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Double-blind, randomized study of the effects of influenza vaccination on the specific antibody response and clinical course of patients with chronic fatigue syndrome.
    Sleigh KM; Danforth DG; Hall RT; Fleming JA; Stiver HG
    Can J Infect Dis; 2000 Sep; 11(5):267-73. PubMed ID: 18159300
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Seasonal influenza vaccines.
    Fiore AE; Bridges CB; Cox NJ
    Curr Top Microbiol Immunol; 2009; 333():43-82. PubMed ID: 19768400
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunization with trivalent inactivated influenza vaccine in partially immunized toddlers.
    Englund JA; Walter EB; Gbadebo A; Monto AS; Zhu Y; Neuzil KM
    Pediatrics; 2006 Sep; 118(3):e579-85. PubMed ID: 16950949
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chronic fatigue syndrome/myalgic encephalomyelitis (CFS/ME) is associated with pandemic influenza infection, but not with an adjuvanted pandemic influenza vaccine.
    Magnus P; Gunnes N; Tveito K; Bakken IJ; Ghaderi S; Stoltenberg C; Hornig M; Lipkin WI; Trogstad L; Håberg SE
    Vaccine; 2015 Nov; 33(46):6173-7. PubMed ID: 26475444
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Influenza vaccine immunogenicity in 6- to 23-month-old children: are identical antigens necessary for priming?
    Walter EB; Neuzil KM; Zhu Y; Fairchok MP; Gagliano ME; Monto AS; Englund JA
    Pediatrics; 2006 Sep; 118(3):e570-8. PubMed ID: 16950948
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A controlled trial of intravenous immunoglobulin G in chronic fatigue syndrome.
    Peterson PK; Shepard J; Macres M; Schenck C; Crosson J; Rechtman D; Lurie N
    Am J Med; 1990 Nov; 89(5):554-60. PubMed ID: 2239975
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Influenza virus vaccine live intranasal--MedImmune vaccines: CAIV-T, influenza vaccine live intranasal.
    Drugs R D; 2003; 4(5):312-9. PubMed ID: 12952502
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Humoral and cellular immune responses after influenza vaccination in patients with chronic fatigue syndrome.
    Prinsen H; de Vries IJ; Torensma R; Pots JM; Mulder SF; van Herpen CM; Elving LD; Bleijenberg G; Stelma FF; van Laarhoven HW
    BMC Immunol; 2012 Dec; 13():71. PubMed ID: 23244635
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunization of institutionalized asthmatic children and patients with psychomotor retardation using live attenuated cold-adapted reassortment influenza A H1N1, H3N2 and B vaccines.
    Miyazaki C; Nakayama M; Tanaka Y; Kusuhara K; Okada K; Tokugawa K; Ueda K; Shibata R; Nishima S; Yamane N
    Vaccine; 1993; 11(8):853-8. PubMed ID: 8356846
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Safety of Russian-backbone seasonal trivalent, live-attenuated influenza vaccine in a phase II randomized placebo-controlled clinical trial among children in urban Bangladesh.
    Ortiz JR; Goswami D; Lewis KD; Sharmeen AT; Ahmed M; Rahman M; Rahman MZ; Feser J; Neuzil KM; Brooks WA
    Vaccine; 2015 Jun; 33(29):3415-21. PubMed ID: 25917680
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Live attenuated influenza vaccine, trivalent, is safe in healthy children 18 months to 4 years, 5 to 9 years, and 10 to 18 years of age in a community-based, nonrandomized, open-label trial.
    Piedra PA; Gaglani MJ; Riggs M; Herschler G; Fewlass C; Watts M; Kozinetz C; Hessel C; Glezen WP
    Pediatrics; 2005 Sep; 116(3):e397-407. PubMed ID: 16140685
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy of a Russian-backbone live attenuated influenza vaccine among children in Senegal: a randomised, double-blind, placebo-controlled trial.
    Victor JC; Lewis KD; Diallo A; Niang MN; Diarra B; Dia N; Ortiz JR; Widdowson MA; Feser J; Hoagland R; Emery SL; Lafond KE; Neuzil KM
    Lancet Glob Health; 2016 Dec; 4(12):e955-e965. PubMed ID: 27746224
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Safety of the trivalent, cold-adapted influenza vaccine in preschool-aged children.
    Piedra PA; Yan L; Kotloff K; Zangwill K; Bernstein DI; King J; Treanor J; Munoz F; Wolff M; Cho I; Mendelman PM; Cordova J; Belshe RB
    Pediatrics; 2002 Oct; 110(4):662-72. PubMed ID: 12359778
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Maternal immunisation with trivalent inactivated influenza vaccine for prevention of influenza in infants in Mali: a prospective, active-controlled, observer-blind, randomised phase 4 trial.
    Tapia MD; Sow SO; Tamboura B; Tégueté I; Pasetti MF; Kodio M; Onwuchekwa U; Tennant SM; Blackwelder WC; Coulibaly F; Traoré A; Keita AM; Haidara FC; Diallo F; Doumbia M; Sanogo D; DeMatt E; Schluterman NH; Buchwald A; Kotloff KL; Chen WH; Orenstein EW; Orenstein LAV; Villanueva J; Bresee J; Treanor J; Levine MM
    Lancet Infect Dis; 2016 Sep; 16(9):1026-1035. PubMed ID: 27261067
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Safety and immunogenicity of trivalent inactivated influenza vaccine in infants: a randomized double-blind placebo-controlled study.
    Englund JA; Walter E; Black S; Blatter M; Nyberg J; Ruben FL; Decker MD;
    Pediatr Infect Dis J; 2010 Feb; 29(2):105-10. PubMed ID: 19934787
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Influenza vaccine for patients with chronic obstructive pulmonary disease.
    Poole PJ; Chacko E; Wood-Baker RW; Cates CJ
    Cochrane Database Syst Rev; 2000; (4):CD002733. PubMed ID: 11034751
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Safety of the trivalent, cold-adapted influenza vaccine (CAIV-T) in children.
    Piedra PA
    Semin Pediatr Infect Dis; 2002 Apr; 13(2):90-6. PubMed ID: 12122958
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A nasally administered trivalent inactivated influenza vaccine is well tolerated, stimulates both mucosal and systemic immunity, and potentially protects against influenza illness.
    Langley JM; Aoki F; Ward BJ; McGeer A; Angel JB; Stiver G; Gorfinkel I; Shu D; White L; Lasko B; Dzongowski P; Papp K; Alexander M; Boivin G; Fries L
    Vaccine; 2011 Feb; 29(10):1921-8. PubMed ID: 21219987
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Influenza vaccination in children primed with MF59-adjuvanted or non-adjuvanted seasonal influenza vaccine.
    Vesikari T; Forstén A; Arora A; Tsai T; Clemens R
    Hum Vaccin Immunother; 2015; 11(8):2102-12. PubMed ID: 26091244
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.